Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018)

Sintx Technologies (SINT) recorded quarterly Cash from Discontinued Operations of 882000.0 in Q4 2018, up 352.31% quarter-over-quarter from 195000.0 in Q3 2018, and down 47.84% on a YoY basis from 1691000.0 in Q4 2017.

Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018) Analysis & Trends

Sintx Technologies' Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 882000.0 for Q4 2018.

  • In Q4 2018, Cash from Discontinued Operations fell 47.84% year-over-year to 882000.0; the TTM figure through Dec 2018 stood at 675000.0 (changed N/A YoY), while the FY2018 annual figure was 675000.0, down 72.42% from the prior year.
  • Cash from Discontinued Operations was 882000.0 for Q4 2018 at Sintx Technologies, up from 195000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 1691000.0 in Q4 2017 to a low of 616000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Sintx Technologies 8.59 Mn 6.70 Mn 144,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2018 882,000.00
Dec 31, 2018 882,000.00
Sep 30, 2018 195,000.00
Sep 30, 2018 195,000.00
Jun 30, 2018 -616,000.00
Jun 30, 2018 -616,000.00
Mar 31, 2018 214,000.00
Mar 31, 2018 214,000.00
Dec 31, 2017 1.69 Mn
Dec 31, 2017 1.69 Mn